beta-lactamase CMY-2
CMY-30 is a mutant of CMY-2 in which glycine replaces valine at position 211; enzyme responsible for cephamycin resistance; isolated from Klebsiella pneumoniae cefoxitin-resistant strain; amino acid sequence given in first source; GenBank X91840
Also Known As:
CMY-2 beta-lactamase; CMY-2 cephalosporinase; CMY-30 beta-lactamase, Citrobacter freundii; bla(CMY-2); bla-CMY-2; cephamycinase bla(CMY-2)
Networked: 4
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Babouee Flury, Baharak:
1 article
(01/2020)
|
2. | Buetti, Niccolo:
1 article
(01/2020)
|
3. | Casanova, Carlo:
1 article
(01/2020)
|
4. | Furrer, Hansjakob:
1 article
(01/2020)
|
5. | Jent, Philipp:
1 article
(01/2020)
|
6. | Livermore, David M:
1 article
(01/2020)
|
7. | Lo Priore, Elia:
1 article
(01/2020)
|
8. | Pelzer, Niklas:
1 article
(01/2020)
|
9. | Fung, Chang-Phone:
1 article
(08/2015)
|
10. | Lin, Tzu-Lung:
1 article
(08/2015)
|
Related Diseases
Related Drugs and Biologics